ArticleClinical ophthalmology (Auckland, N.Z.)2011

Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors.

Samuel K Houston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.